Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0024141 (
systemic lupus erythematosus
)
44,322
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The effect of plasmapheresis in 8 patients with
systemic lupus erythematosus
(
SLE
) was investigated. Drug treatment was maintained at a constant level for at least 4 weeks before plasmapheresis. Levels of immune complexes were measured by a
Raji
cell radioimmunoassay, and by a solid-phase C1q-binding assay. Antibodies to ds-DNA and ss-DNA were measured by the Farr assay. In all cases, immune complexes and antibodies were lowered by plasmapheresis. In 5 patients, plasmapheresis was followed by a rapid rebound of complexes and antibody to pretreatment levels. In 3 in whom plasmapheresis was followed by treatment with cyclophosphamide for 1 month, a sustained immunochemical and clinical improvement followed, lasting in 2 cases for up to 3 years.
...
PMID:Therapeutic plasmapheresis in systemic lupus erythematosus. Effect on immune complexes and antibodies to DNA. 697 35
The
Raji
cell assay is regarded as a test for the detection and quantitation of immune complexes. It is frequently positive in sera from patients with
SLE
. We have demonstrated a relationship between
Raji
cell binding and antibodies to DNA and soluble cellular antigens. In five sera containing high titres of antibodies of known single specificity, most of the
Raji
cell binding occurred in the 7S IgG fraction where the majority of anti-nuclear antibody was also found. When each of these sera was incubated with its specific antigen,
Raji
cell binding increased. Subsequent fractionation showed that this binding was in the high molecular weight fraction (greater than 200,000 daltons) and that
Raji
cell binding and antibody activity were abolished in the 7S fraction. These data confirm that
Raji
cell bind immune complexes but also indicate that 7S anti-nuclear antibodies may interact directly with
Raji
cells by an unknown mechanism. Therefore, in sera of patients with anti-nuclear antibodies, binding to
Raji
cells does not necessarily imply the presence of immune complexes alone.
...
PMID:Interpretation of the Raji cell assay in sera containing anti-nuclear antibodies and immune complexes. 697 76
A solid phase radioassay for measurement of ICs in biological fluids is described in which ICs present in test sample bind to C1q immobilized on latex particles and bound complexes are quantitated by reaction with radioiodinated mRF. The radioassay can reproducibly measure 10 ng of aggregated human IgG in serum and differentiate soluble complexes from IC-like materials that precipitate with centrifugation or low temperature or stick to test tube walls. Reagents used in the assay, including C1q-L, can be stored for extended periods of time before use. One hundred four of 171 sera from patients with
SLE
and 8 of 50 sera from patients with LC, assayed by this method, contained elevated levels of ICs relative to controls . IC levels determined by this method correlated with IC data generated by 125I-C1q-PEG precipitation.
Raji
cell radioimmune assay, and solid-phase conglutinin assay, in some cases but not other.
...
PMID:C1q-latex assay for immune complexes. Complexes that react with both C1q and monoclonal rheumatoid factor in lupus erythematosus and lung cancer. 697 70
Sera from 50 patients with well-defined ankylosing spondylitis were examined for circulating immune complexes using both a Clq binding (fluid phase) assay and a
Raji
cell assay. No more than five of the patients assessed had circulating immune complexes by either one of these techniques and none were positive in both. This result is in contrast to the high prevalence in sera from unselected patients with rheumatoid arthritis and systemic
lupus
used as positive controls.
...
PMID:The absence of circulating immune complexes in patients with ankylosing spondylitis. 698 Nov 82
We asked whether binding of human immunoglobulin (Ig)G antibody reacting with
Raji
cells could be distinguished from binding of IgG immune complexes. Using a standard
Raji
assay employing 125I-IgG goat anti-human Fc gamma, we found that digestion of
Raji
cells with pronase reduced by 95% their ability to bind complement-fixed aggregated human gamma globulin and complement-fixed tetanus toxoid-antitetanus toxin complexes. However, binding at 37 degrees C of IgG from the sera of 16 patients with
systemic lupus erythematosus
(
SLE
) to pronase-digested
Raji
cells was reduced much less consistently and extensively (9-100% reduction; mean reduction of 51%). In more detailed studies of two
SLE
sera, sucrose density gradient centrifugation showed that greater than 50% of the IgG binding to undigested
Raji
cells sedimented in the 7S region. Pepsin digestion of immunoglobulin fractions from four
SLE
sera caused a reduction in
SLE
IgG binding to undigested
Raji
cells when detected with 125I anti-Fc gamma, but an increase when binding was detected with 125I-anti-Fab, suggesting that substantial
SLE
IgG can bind through F(ab')2 regions. Binding of IgG from
SLE
sera was not directed at neoantigenic sites induced by pronase digestion because binding activity was adsorbed with undigested cells as readily as with digested cells. Moreover, sera from 10
SLE
patients that had negative
Raji
assays contained no IgG that bound to pronase-digested
Raji
cells. We conclude that much of the IgG bound at 37 degrees C to
Raji
cells from the sera of many patients with
SLE
does not represent immune complexes but is probably antibody directed toward sites on the
Raji
cell.
...
PMID:Raji cell assay for immune complexes. Evidence for detection of Raji-directed immunoglobulin G antibody in sera from patients with systemic lupus erythematosus. 699 84
Ten of 143
systemic lupus erythematosus
patients demonstrated urticaria-like lesions. Lesional biopsies in 7 of 9 patients tested revealed a leukocytoclastic angiitis and in 2, a mononuclear perivascular infiltrate. Direct immunofluorescent studies in 2 of 6 patients tested revealed IgM and C3 deposition in and about dermal blood vessels. Nine of the 10
systemic lupus erythematosus
, patients displayed active clinical disease (e.g., arthritis, renal disease, etc.), a positive
lupus
band test, antibodies against deoxyribonucleic acid or Sm macromolecules, serum hypocomplementemia and markedly elevated quantities of serum immune complexes as determined by an immunoradiometric assay employing
Raji
cells. Similar lesions were not detected in 35 discoid lupus erythematosus patients. These studies strongly suggest: (1) urticaria-like lesions are uncommon cutaneous manifestations of
systemic lupus erythematosus
. (2) These urticaria-like lesions do not represent a classic IgE mediated urticaria. (3) These urticaria-like lesions generally occur in lupus erythematosus patients demonstrating clinical and/or serological evidence of systemic disease activity. (4) These lesions are probably secondary to immune complex deposition. We, therefore, conclude that all urticarial lesions in lupus erythematosus patients should be biopsied and the patient evaluated for active systemic disease.
...
PMID:Unusual cutaneous manifestations of systemic lupus erythematosus: I. Urticaria-like lesions. Correlation with clinical and serological abnormalities. 700 29
The presence of biliary tract antigens in circulating immune complexes from patients with primary biliary cirrhosis (PBC) was investigated. Concentrations of immune complexes in PBC sera, measured by the
Raji
cell immunoassay, ranged from 58 to greater than 1,000 microgram/ml, but did not correlate with disease activity. Immunofluorescent staining of complexes bound to
Raji
cells was carried out with guinea-pig antiserum raised against biliary tract antigens. Positive staining reactions were observed with complexes obtained from PBC patients, but not with those obtained from patients with
systemic lupus erythematosus
or rheumatoid arthritis, indicating that in PBC antigenic components associated with the biliary tract are contained within the complexes.
...
PMID:Identification of biliary antigens in circulating immune complexes in primary biliary cirrhosis. 700 76
The sera of 31 patients with primary IgA nephropathy were investigated for IgA containing immune complexes by
Raji
cell-binding IgA radioimmunoassay and conglutinin-binding IgA radioimmunoassay. Positive results, without correlation with IgA serum levels, were found in 68% of the patients using the first assay, in 39% of the patients with the second assay. Positive sera were analysed by gel chromatography. Conglutinin-binding IgA eluted in two peaks, a minor one of 400,000-800,000 daltons mol. wt and a major one corresponding to monomeric IgA. No increase of secretory IgA and of polymeric IgA was detectable. IgA immune complexes were likewise found in the sera of patients with systemic
lupus
(five of 12), rheumatoid arthritis (four of 12), subacute bacterial endocarditis (four of 12) and HB virus hepatitis (four of 16). However, the high prevalence on these sera of IgG and IgM immune complexes detected by polyethylene glycol precipitation, solid phase Clq binding assay contrasted strongly with their absence in IgA nephropathy. In addition, the presence of abnormal amounts of conglutinin reactive IgA correlated with the recurrence of IgA deposits after renal transplantation (20 patients studied). Conglutinin reactive IgA could contribute to the glomerular deposition of IgA and subsequently play a significant role in the pathogenesis of IgA nephropathy.
...
PMID:Analysis of circulating IgA and detection of immune complexes in primary IgA nephropathy. 704 34
Sera from 21 patients with
systemic lupus erythematosus
(
SLE
) were tested with a platelet factor 3 (PF3) assay. A control serum (pooled blood group AB serum) was always run in parallel with the test sera. The test and control sera were run in duplicate and for each patient the mean recalcification time was used for the calculation of the test serum: AB serum ratio. Concomitantly, the patients' serum concentrations of circulating immune complexes (CIC) were measured by using the
Raji
cell radioimmunoassay. 20 healthy hospital employees served as controls. In the latter subjects the mean test serum: AB serum ratio was 0.99 (range 0.92-1.09), their CIC concentrations being less than or equal to 16 micrograms/ml. 7 of the
SLE
patients had CIC values less than or equal to 16 micrograms/ml, and their test serum: AB serum ratios ranged 0.95-1.09. All the remaining
SLE
patients had elevated values for CIC. In the total material of
SLE
there was a highly significant (r = -0.87; P less than 0.001) negative correlation between the test serum: AB serum ratios and the values for CIC. It is widely held that the so-called PF3 immunoinjury test detects circulating antiplatelet antibodies. The present results, however, strongly suggest that the assay rather or also detects CIC which like antiplatelet antibodies may damage platelets as we and others have shown in prior publications.
...
PMID:The platelet factor 3 assay and circulating immune complexes as studied on non-thrombocytopenic patients with systemic lupus erythematosus. 712 53
Sera from patients with multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), subacute sclerosing panencephalitis (SSPE), and myasthenia gravis (MG) were assayed for immune complexes. Three techniques were used: a modified
Raji
cell assay, the 125I-Clq polyethyleneglycol assay, and a solid-phase clq assay. Immune complex levels were elevated in sera of some patients with MS, ALS, and SSPE, but the elevations were modest when compared with active
systemic lupus erythematosus
(
SLE
). In some cases, abnormalities were detected in only one assay system; in other cases, abnormalities were detected by two or three assay systems. In MS, immune complex elevations correlated with active disease and with decreased suppressor cell activity. Of two ALS patients with antecedent poliomyelitis, one had markedly increased levels of immune complexes in two assays. In MG, levels of immune complexes did not differ from those of controls.
...
PMID:Circulating immune complexes in neurologic disease. 719 88
<< Previous
1
2
3
4
5
6
7
Next >>